期刊文献+

乳腺疾病患者血清中IFN-γ的检测及临床意义

The detection and clinical significance of IFN-γ in breast diseases
下载PDF
导出
摘要 目的:检测乳腺疾病患者及对照组患者血清中IFN-γ的水平,分析其临床意义。方法:收集2014年3月至2015年3月我院转移性乳腺癌患者30例、局部乳腺癌患者35例、乳腺不典型增生患者29例、乳腺纤维瘤患者31例、正常人群30例。应用酶联免疫吸附试验(ELISA法)定量检测IFN-γ在不同组织血清中的水平。比较乳腺癌组与其他各组间血清IFN-γ水平的差异,同时分析乳腺癌组血清中IFN-γ水平与临床病理特征间的关系,探讨检测IFN-γ的临床意义。结果:转移性乳腺癌患者血清中IFN-γ水平明显高于局部乳腺癌组、乳腺不典型增生组、乳腺纤维瘤组及正常人群组,经统计学分析差异均具有统计学意义(F=142.48,P<0.05)。乳腺不典型增生组、乳腺纤维瘤组及正常人群组血清中IFN-γ的组间表达差异无统计学意义(P>0.05)。乳腺癌患者中IFN-γ的表达水平与年龄和肿瘤大小无关(P>0.05),而与TNM分期、组织学分级、淋巴结状态及脉管浸润有关,差异具有统计学意义(P<0.05)。结论:IFN-γ血清水平与乳腺癌发生及侵袭转移相关,可作为一个潜在的乳腺癌血清标志物。 Objective: To detect the level of IFN - γ, in breast disease patients and control group, analyze its clini- cal significance. Methods : Collect 30 metastatic breast cancer patients' serum, 35 patients' serum of localized breast cancer, 29 patients' serum of atypical hyperplasia of the breast,31 mammary gland fibroma patients' serum and 30 nor- mal people's serum. Use the ELISA method to quantitatively detect the level of IFN -γ. Results:The level of IFN -γ in metastatic breast cancer patients' serum was apparently higher than localized breast cancer group, atypical hyperpla- sia of the breast group ,mammary gland fibroma group and normal population group ( F = 142.48 ,P 〈0.05 ). The lev- els of IFN - γ in atypical hyperplasia of the breast group, mammary gland fibroma group and normal population group had no difference ( P 〉 0. 05 ). There was no relationship among age, tumor size and the expression level of IFN - γ, in breast cancer patients ( P 〉 0. 05 ), but among TNM staging, histological grade, node status and vascular lymphatic in- vasion, the differences were significant ( P 〈 0.05 ). Conclusion: IFN - γ is related to the genesis and invasion of breast cancer,it is a potential biomarker for breast cancer diagnosis.
出处 《现代肿瘤医学》 CAS 2015年第21期3104-3106,共3页 Journal of Modern Oncology
关键词 乳腺癌 血清标志物 IFN-Γ breast cancer, serum biomarker, IFN -γ
  • 相关文献

参考文献13

  • 1Ataollahi M,Sedighi S,Masoumi SZ.Nutritional and unhealthy behaviors in women with and without breast cancer[J].Iranian Red Crescent Med J,2014,16(9):e19684.
  • 2Zeng H,Zheng R,Zhang S,et al.Female breast cancer statistics of 2010 in China:estimates based on data from 145 population-based cancer registries[J].J Thoracic Dis,2014,6(5):466-470.
  • 3Ren F,Fan M,Mei J,et al.Interferon-gamma and celecoxib inhibit lung-tumor growth through modulating M2/M1 macrophage ratio in the tumor microenvironment[J].Drug Design,Development and Therapy,2014,8:1527-1538.
  • 4Stahl P,Ruppert V,Schwarx RT,et al.Trypanosoma cruzi evades the protective role of interferon-gamma-signaling in parasite-infected cells[J].Plos One,2014,9(10):e110512.
  • 5Nowak M,Glowacka E,Szpakowski M,et al.Proinflammatory and immunosuppressive serum,ascites and cyst fluid cytokines in patients with early and advanced ovarian cancer and benign ovarian tumors[J].Neuroendocrinol Lett,2010,31(3):375-383.
  • 6Wee ZN,Li Z,Lee PL,et al.EZH2-mediated inactivation of IFN-gamma-JAK-STAT1 signaling is an effective therapeutic target in MYC-driven prostate cancer[J].Cell Reports,2014,8(1):204-216.
  • 7Zhao Q,Tong L,He N,et al.IFN-gamma mediates graft-versus-breast cancer effects via enhancing cytotoxic T lymphocyte activity[J].Exp Therapeutic Med,2014,8(2):347-354.
  • 8Yang X,Du J,Xu X,et al.IFN-gamma-secreting-mesenchymal stem cells exert an antitumor effect in vivo via the TRAIL pathway[J].J Immunol Res,2014,2014:318098.
  • 9Csiszar A,Szentes T,Haraszti B,et al.The pattern of cytokine gene expression in human colorectal carcinoma[J].Pathol Oncol Res,2004,10(2):109-116.
  • 10徐新生,郭晓静,刘芳芳,李伟东,刘冰冰,谷峰,郎荣刚,范宇,付丽.浸润性T淋巴细胞及Th细胞因子在不同类型乳腺癌中的表达[J].中华乳腺病杂志(电子版),2009,3(6):28-33. 被引量:3

二级参考文献33

  • 1陈凌,范宇,郎荣刚,郭晓静,孙玉兰,付丽.伴有浸润性微乳头状癌结构乳腺癌的诊断和预后研究[J].中华病理学杂志,2007,36(4):228-232. 被引量:17
  • 2Agarwal A, Ran i M, Saha G K, et al. Disregulated expression of the Th2 cytokine gene in patients with intraoral squamous cell carcinoma. Immunol Invest, 2003,32:17-- 30.
  • 3Todaro M, Zerilli M, RicciVitiani 1.. Autocrine production of interleukin-4 and interleukin-10 is required for survival and growth of thyroid cancer cells. Cancer Res, 2006, 66: 1491--1499.
  • 4Abehsira Amar O, Gibert M, Joliy M, et al. IL-4 plays a dominant role in the differential developmenl of Tho into Th1 andTh2 cells. J Immunol. 1992, 148:3820-3829.
  • 5HoskenNA, ShibuyaK, HeathAW, etal. The effect of antigen dose on CD4^+ T helper cell phenotype development in a T cell receptor-alpha beta-transgenie model. J Exp Med, 1995,182:1579-- 1584.
  • 6Pfeiffer C, Stein S, Southwood S, et al. Altered peptide ligands can control CD4 T lymphocyte differentiation in vivo. J Exp Med, 1995, 181:1569--1574.
  • 7Constant S, Pfeiffer C, T. Woodard A, et al. Extent of T cell receptor ligation can determine the function differentiation of naive CD4^+ T cells. J Exp Med, 1995, 182:1591-- 1596.
  • 8Reinhard G, Noll A, Schlebusch H, et al. Shifts in the Th1/Th2 balance during human pregnancy correlate with apoptotic changes. Biochem Biophys Res Commun, 1998, 245:933--938.
  • 9Tsuta K, Ishii G, Kim E, et al. Primary lung adenocarcinoma with massive lymphocyte infiltration. AmJ Clin Pathol, 2005, 123:547--552.
  • 10Canna K, McArdle P A, McMillan D C, etal. The relationship between tumour T-lymphocyte infiltration, the systemic inflammatory response and survival in patients undergoing curative resection for colorectal cancer. Br J Cancer, 2005, 92:651--654.

共引文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部